Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver

European Journal of Pharmacology

Volumn 668, Issue 3, 2011, Pages 467-471

  Xing, Lian Jun ^a   Zhang, Li ^a   Liu, Tao ^a   Hua, Yong Qiang ^a   Zheng, Pei Yong ^a   Ji, Guang ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Berberine; Insulin receptor substrate 2 (IRS 2); Insulin resistance; Nonalcoholic fatty liver disease (NAFLD); Pioglitazone

Indexed keywords

BERBERINE; BIOCHEMICAL MARKER; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; PIOGLITAZONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EPIDIDYMIS FAT; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BERBERINE; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; RATS; RATS, WISTAR; RECEPTOR, INSULIN; RNA, MESSENGER; UP-REGULATION;

EID: 80053572802     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.07.036     Document Type: Article

References (24)

1. Z.T. Bloomgarden Inflammation and insulin resistance Diabetes Care 26 2003 1922 1926 (Pubitemid 36929145)
2. J. Choudhury, and A.J. Sanyal Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease Clin. Liver Dis. 8 2004 575 594 ix (Pubitemid 39141144)
3. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
4. A.M. Diehl, Z. Goodman, and K.G. Ishak Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury Gastroenterology 95 1988 1056 1062
5. M.S. Gauthier, K. Couturier, J.G. Latour, and J.M. Lavoie Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis J. Appl. Physiol. 94 2003 2127 2134 (Pubitemid 36605269)
6. Y. Hu, and G.E. Davies Berberine inhibits adipogenesis in high-fat diet-induced obesity mice Fitoterapia 81 2010 358 366
7. R.G. Knodell, K.G. Ishak, W.C. Black, T.S. Chen, R. Craig, N. Kaplowitz, T.W. Kiernan, and J. Wollman Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435 (Pubitemid 12218164)
8. E.W. Kraegen, D.E. James, S.P. Bennett, and D.J. Chisholm In vivo insulin sensitivity in the rat determined by euglycemic clamp Am. J. Physiol. 245 1983 E1 7
9. Y.S. Lee, W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, Y. Shen, J.M. Ye, C.H. Lee, W.K. Oh, C.T. Kim, C. Hohnen-Behrens, A. Gosby, E.W. Kraegen, D.E. James, and J.B. Kim Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states Diabetes 55 2006 2256 2264 (Pubitemid 44743622)
10. S.H. Leng, F.E. Lu, and L.J. Xu Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion Acta Pharmacol. Sin. 25 2004 496 502
11. L.Z. Liu, S.C. Cheung, L.L. Lan, S.K. Ho, H.X. Xu, J.C. Chan, and P.C. Tong Berberine modulates insulin signaling transduction in insulin-resistant cells Mol. Cell. Endocrinol. 317 2010 148 153
12. A. McCullough The epidemiology and risk factors of NASH G.C. Farrell, Fatty Liver Disease: NASH and Related Disorders 2005 Blackwell Publishing Malden, MA 23 37
13. S.F. Previs, D.J. Withers, J.M. Ren, M.F. White, and G.I. Shulman Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo J. Biol. Chem. 275 2000 38990 38994 (Pubitemid 32058910)
14. S. Saadeh Nonalcoholic fatty liver disease and obesity Nutr. Clin. Pract. 22 2007 1 10 (Pubitemid 46175466)
15. V.T. Samuel, Z.X. Liu, X. Qu, B.D. Elder, S. Bilz, D. Befroy, A.J. Romanelli, and G.I. Shulman Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J. Biol. Chem. 279 2004 32345 32353 (Pubitemid 39014687)
16. C.E. Taylor, and W.B. Greenough III Control of diarrheal diseases Annu. Rev. Public Health 10 1989 221 244 (Pubitemid 19137980)
17. K.M. Utzschneider, and S.E. Kahn Review: the role of insulin resistance in nonalcoholic fatty liver disease J. Clin. Endocrinol. Metab. 91 2006 4753 4761 (Pubitemid 44917301)
18. A.M. Valverde, D.J. Burks, I. Fabregat, T.L. Fisher, J. Carretero, M.F. White, and M. Benito Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes Diabetes 52 2003 2239 2248 (Pubitemid 37059493)
19. P. Vollenweider, B. Menard, and P. Nicod Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance Diabetes 51 2002 1052 1059 (Pubitemid 34438349)
20. C. Wang, J. Li, X. Lv, M. Zhang, Y. Song, L. Chen, and Y. Liu Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin Eur. J. Pharmacol. 620 2009 131 137
21. D.J. Withers, J.S. Gutierrez, H. Towery, D.J. Burks, J.M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G.I. Shulman, S. Bonner-Weir, and M.F. White Disruption of IRS-2 causes type 2 diabetes in mice Nature 391 1998 900 904 (Pubitemid 28157668)
22. J. Yin, H. Xing, and J. Ye Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism 57 2008 712 717 (Pubitemid 351608234)
23. J. Zhang, J. Chen, T. Y., and L. HX. Preventive effect of pioglitazone against nonalcoholic fatty liver disease in Sprague-Dawley rats and its mechanism Shijie Huaren Xiaohua Zazhi 17 2009 758 764
24. L. Zhao, W. Li, F. Han, L. Hou, J.P. Baillargeon, H. Kuang, Y. Wang, and X. Wu Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro Fertil Steril 95 2011 461 463